Skip to content
DraconiticResearch
Search Sources API
186,086 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BYMedComm

Baricitinib as Salvage Therapy for Multidrug-Resistant Chronic Graft-Versus-Host Disease.

  1. 1Peking University People's Hospital Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University Beijing China.

Related

  1. Therapeutic Plasma Exchange as Salvage Therapy in Paediatric Fulminant Hepatitis A Complicated by Acute Kidney Injury and Multidrug-Resistant Pneumonia: A Case Report
    Yatri Patel, Vatsal Goswami, Uttam Gondalia +2
    CureusPeer-reviewedCC BYFull textInfectious diseaseEurope PMCEurope PMCPMC
  2. Nursing care of a child with cerebral palsy and multidrug-resistant bacterial pneumonia treated with bacteriophage therapy: a case report
    Lu Wang, Chunyan Lu, Huiwen Li +1
    Frontiers in pediatricsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Case Report: Low-dose radiotherapy as part of multimodal salvage therapy for immunotherapy-resistant SMARCA4-deficient non-small cell lung cancer.
    Tong Bu, Nan Zhang, Tong Jin +5
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  4. Early best available antibiotic therapy for multidrug-resistant gram-negative bloodstream infections: a target trial emulation
    Luca Mezzadri, Wei Cong Tan, Xinxin Hao +102
    eClinicalMedicinePeer-reviewedCC BY 4.0General medicineCrossref
  5. Temporal proximity to counseling is associated with longitudinal bedaquiline and antiretroviral therapy adherence in multidrug-resistant tuberculosis and HIV treatment
    Xuan Lu, Jennifer Zelnick, Meng Zhao +12
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyMicrobiologyPLOS
BibTeX
@article{an2026baricitinib,
  title = {{Baricitinib as Salvage Therapy for Multidrug-Resistant Chronic Graft-Versus-Host Disease.}},
  author = {Zhuo-Yu An and Chen Zhao and Yuanyuan Zhang and Xiaodong Mo and Leqing Cao and Daoxing Deng and Jun Kong and Fengrong Wang and Xiaojun Huang and Xiaohui Zhang},
  journal = {MedComm},
  year = {2026},
  month = oct,
  doi = {10.1002/mco2.71094},
  url = {https://europepmc.org/article/MED/42948231},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Baricitinib as Salvage Therapy for Multidrug-Resistant Chronic Graft-Versus-Host Disease.
AU  - Zhuo-Yu An
AU  - Chen Zhao
AU  - Yuanyuan Zhang
AU  - Xiaodong Mo
AU  - Leqing Cao
AU  - Daoxing Deng
AU  - Jun Kong
AU  - Fengrong Wang
AU  - Xiaojun Huang
AU  - Xiaohui Zhang
PY  - 2026
DA  - 2026/10/27
JO  - MedComm
DO  - 10.1002/mco2.71094
UR  - https://europepmc.org/article/MED/42948231
SN  - 2688-2663
ER  -